Federal Register
Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance- Facts included
- The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3‑chloromethcathinone; 3‑CMC) in schedule I of the Controlled Substances Act (CSA).
- 3‑chloromethcathinone is not specifically listed in schedule I of the CSA with its own unique drug code.
- The DEA is amending the schedule I hallucinogenic substances list in its regulations to separately include 3‑chloromethcathinone.
- Sourcing
- Low – the article relies solely on its own statement without external citations, official documents, or corroborating sources.
- Framing
- The piece presents itself as a factual report of a regulatory action without offering analysis or opinion; however, it makes an unsupported claim about the hallucinogenic status of 4‑chloromethcathinone.
- Omissions
- The article does not provide context about the legal process for adding a substance to Schedule I, the criteria used by the DEA, any public comment period, the potential impact on users or researchers, or health and safety information about 3‑CMC.
- Rhetorical notes (3)
- Framing · Technical Jargon · Causal Claim